RAF-MEK-ERK pathway in cancer evolution and treatment

Cited by (557)

Items 101–200 of 557

1. LncRNA SNHG25 Promotes Glioma Progression Through Activating MAPK Signaling
   Zeyu Wu, Peng Lun, Tao Ji, Jiaojiao Niu, Xiuyan Sun, Xia Liu, Jian Yu Xu · 2022 · Molecular Neurobiology
2. The Role of Cocaine- and Amphetamine-Regulated Transcript (CART) in Cancer: A Systematic Review
   Maja Owe-Larsson, Jan Pawłasek, Tomasz Piecha, Alicja Sztokfisz-Ignasiak, M M Pater, Izabela Róża Janiuk · 2023 · International Journal of Molecular Sciences
3. Prolonged exposure to environmental levels of microcystin-LR triggers ferroptosis in brain via the activation of Erk/MAPK signaling pathway
   Lingyun Zhu, Pingping Cao, Suisui Yang, Fan Lin, Jing Wang · 2023 · Ecotoxicology and Environmental Safety
4. FBXO22 promotes HCC angiogenesis and metastasis via RPS5/AKT/HIF-1α/VEGF-A signaling axis
   Zhen Lei, Yiming Luo, Junli Lu, Qinggang Fu, Chao Wang, Qian Chen, Zhiwei Zhang, Long Zhang · 2025 · Cancer Gene Therapy
5. ErbB/HER family in cancer immunology: therapeutic advances and mechanisms
   Ling Yin, Hongliang Zhang, Yuhua Shang, Songquan Wu, Tengchuan Jin · 2025 · Drug Discovery Today
6. Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
   Lian Zhou, Shilong Xu, Siwen Li · 2025 · Pharmaceutics
7. CC chemokines Modulate Immune responses in Pulmonary Hypertension
   Qian Yan, Shasha Liu, Yang Sun, Chen Chen, Yantao Yang, Songwei Yang, Meiyu Lin, Junpeng Long, Yuting Lin, Jinping Liang et al. · 2023 · Journal of Advanced Research
8. Novel RAF ‐directed approaches to overcome current clinical limits and block the RAS / RAF node
   Rossella Scardaci, Ewa Berlinska, Pietro Scaparone, Sandra Vietti Michelina, Edoardo Garbo, Silvia Novello, David Santamarı́a, Chiara Ambrogio · 2024 · Molecular Oncology
9. Exploring Small-Molecule Inhibitors Targeting MAPK Pathway Components: Focus on ERK, MEK1, and MEK2 Kinases in Cancer Treatment
   Tuhin Mukherjee, Satyajit Mohanty, Jasleen Kaur, Mayukh Das, Krishnendu Adhikary, Prity Chatterjee, Rajkumar Maiti · 2024 · Chemical Biology Letters
10. EPHB4-RASA1 Inhibition of PIEZO1 Ras Activation Drives Lymphatic Valvulogenesis
    Di Chen, Yipei Tang, Philip Edward Lapinski, David Wiggins, Eva Marie Sevick-Muraca, Michael J. Davis, Philip D. King · 2024 · Circulation Research
11. Small Molecule B-RAF Inhibitors as Anti-Cancer Therapeutics: Advances in Discovery, Development, and Mechanistic Insights
    Yamile Abuchard Anaya, Ricardo Pequeno Bracho, Subhash Chandra Chauhan, Manish Kumar Tripathi, Debasish Bandyopadhyay · 2025 · International Journal of Molecular Sciences
12. Effect of Herniarin on Cell Viability, Cell Cycle, and Erk Protein Levels in Different Stages of Bladder Cancer Cells
    Tuba Özdemir Sancı, Emine Terzi, Beyza Ecem ÖZ BEDİR, Mehmet Gümüştaş, Tuba Aydın, Ahmet Çakır · 2024 · Chemistry & Biodiversity
13. Effects of Physical Cues on Stem Cell-Derived Extracellular Vesicles toward Neuropathy Applications
    Danyale Berry, Justice Ene, Aakash Nathani, Mandip S. Singh, Yan Li, Changchun Zeng · 2024 · Biomedicines
14. Identification and validation of a lactate metabolism-related six-gene prognostic signature in intrahepatic cholangiocarcinoma
    Chen Sang, Yan Li, Jian Lin, Youpei Lin, Qiang Gao, Xia Shen · 2024 · Journal of Cancer Research and Clinical Oncology
15. A review of CDKL: An underestimated protein kinase family
    Chenrui Li, Yan Liu, Shilu Luo, Ming Jun Yang, Li Li, Lin Sun · 2024 · International Journal of Biological Macromolecules
16. Rupatadine-inhibited OTUD3 promotes DLBCL progression and immune evasion through deubiquitinating MYL12A and PD-L1
    Ying Sui, Ziyang Shen, Xiaoyou Li, Ya Lu, SiTong Feng, Rong Ma, Jianzhong Wu, Changwen Jing, Zhuo Wang, Jifeng Feng et al. · 2024 · Cell Death and Disease
17. Novel drug delivery systems in colorectal cancer: Advances and future prospects
    Raj Kamal, Ankit Awasthi, Priyanka Paul, Mohammad Shabab Mir, Sachin Kumar Singh, Kamal Dua · 2024 · Pathology - Research and Practice
18. ZDHHC2 promoted antimycobacterial responses by selective autophagic degradation of B-RAF and C-RAF in macrophages
    Junli Sheng, Xiaolong You, Dingnai Nie, Yuling Fu, Qiao Ling, Xiaodan Yang, Yitian Chen, Li Ma, Shengfeng Hu · 2025 · Science Advances
19. CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis
    Fan Zhang, Dexian Wei, Shishun Xie, Liqun Ren, Sennan Qiao, Liying Li, Jiahua Ji, Zhimin Fan · 2024 · iScience
20. Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment
    Alexandru Isaic, Lavinia Davidescu, Alexandru Cătălin Motofelea, Tudor Ciocârlie, Nadica Motofelea, Dan Costăchescu, Monica Steluta Marc, Noemi Suppini, Alina Simona Şovrea, Răzvan Lucian Coșeriu et al. · 2024 · International Journal of Molecular Sciences
21. CD44 variant exons induce chemoresistance by modulating cell death pathways
    Maria Yanova, Е. В. Степанова, Diana V. Maltseva, Alexander Tonevitsky · 2025 · Frontiers in Cell and Developmental Biology
22. Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis
    Danila Del Rio, Ilenia Masi, Valentina Caprara, Francesca Spadaro, Flavia Ottavi, Raffaele Strippoli, Pilar Sandoval, Manuel López‐Cabrera, Ricardo Sáinz de la Cuesta, Anna Bagnato et al. · 2021 · Frontiers in Cell and Developmental Biology
23. Oncogenic BRAF noncanonically promotes tumor metastasis by mediating VASP phosphorylation and filopodia formation
    Wenting Pan, Yihao Tian, Qian Zheng, Zelin Yang, Yulong Qiang, Zun Zhang, Nan Zhang, Jie Xiong, Xin Zhu, Lei Wei et al. · 2023 · Oncogene
24. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization
    Camille A. McAloney, Rawan Makkawi, Yogesh Budhathoki, Matthew V. Cannon, Emily Franz, Amy C. Gross, Maren Cam, Tatyana A. Vetter, Rebekka Duhen, Alexander E. Davies et al. · 2023 · Cellular Oncology
25. A web portal for exploring kinase-substrate interactions
    John A. P. Sekar, Yan Chak Li, Avner Schlessinger, Gaurav Shankar Pandey · 2024 · npj Systems Biology and Applications
26. Metabolism: an important player in glioma survival and development
    Ning Wang, Yiru Yuan, Tianhao Hu, Huizhe Xu, Haozhe Piao · 2024 · Discover Oncology
27. PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond
    Sameh Saber, Rasha Abdelhady, Mai Abdallah Elhemely, Elsayed A. Elmorsy, Rabab S. Hamad, Mustafa Ahmed Abdel‐Reheim, Attalla Farag El-kott, Mohammed A. AlShehri, Kareem Morsy, Ali S. Alsheri et al. · 2024 · Frontiers in Pharmacology
28. Inhibition of ERO1L induces autophagy and apoptosis via endoplasmic reticulum stress in colorectal cancer
    Peng Chen, Yinhao Chen, Amit Sharma, A. Gonzalez-Carmona Maria, Ingo G.H. Schmidt‐Wolf · 2024 · Cellular Signalling
29. ERK Allosteric Activation: The Importance of Two Ordered Phosphorylation Events
    Clil Regev, Hyunbum Jang, Ruth Nussinov · 2025 · Journal of Molecular Biology
30. The Cytotoxic Activity of Secondary Metabolites from Marine-Derived Penicillium spp.: A Review (2018–2024)
    Shuncun Zhang, Huannan Wang, Chunmei Sai, Yan Wang, Zhongbin Cheng, Zhen Zhang · 2025 · Marine Drugs
31. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues
    Robert J. Kreitman, Evgeny Arons · 2021 · Blood Reviews
32. EFEMP2 increases the invasion ability of cervical cancer cells by promoting EMT via the Raf/MEK/ERK signaling pathway
    Na Li, Guo-Xin Ji, Ziyan Yang · 2022 · Neoplasma
33. Evolution of mitogen-activated protein kinase family and their immune function in Apostichopus japonicus
    Yuanlan Wu, Xuelin Zhao, Yangxi Xiang, Ming Hao Guo, Chenghua Li · 2022 · Developmental & Comparative Immunology
34. Advances in ERK Signaling Pathway in Traumatic Brain Injury: Mechanisms and Therapeutic Potential
    Xingyu Wang, Qisheng Wang, Liming Hou, Gang Wei, Chenshu He, Haopeng Li, Liang Liu · 2025 · Neurochemical Research
35. Responsive mesoporous silica nanocarriers in glioma therapy: A step forward in overcoming biological barriers
    Yasmeen T Abdel-Maksoud, Ahmed Helmy Abdelhaseb, Amr Abd-Elraheem Abdo, Ahmed Mohamed Kamel, Mohamed T. Elsebay, Mohamed Salah Attia · 2025 · World Journal of Clinical Oncology
36. Promoting effect and immunologic role of secretogranin II on bladder cancer progression via regulating MAPK and NF-κB pathways
    Jiawei Zhou, Caitao Dong, Jing Tan, Guijun Wang, Zhen Li, Sheng Li, Ziqi He · 2023 · APOPTOSIS
37. Silencing LY6D Expression Inhibits Colon Cancer in Xenograft Mice and Regulates Colon Cancer Stem Cells’ Proliferation, Stemness, Invasion, and Apoptosis via the MAPK Pathway
    Jinyue Duan, Yi Wang, Yuanyuan Chen, Yujue Wang, Qisen Li, Jinrui Liu, Changhao Fu, Chenyu Cao, Zhongyi Cong, Manman Su · 2023 · Molecules
38. Diverse functions of Tribbles homolog 3 in cancers and its potential as a therapeutic target
    Shiying Lei, Jiajun Sun, Yifang Xie, Xiaojuan Xiao, Xiao‐Feng He, Sheng Lin, Huifang Zhang, Zineng Huang, Haiqin Wang, Xusheng Wu et al. · 2024 · Carcinogenesis
39. Mechanisms of Bone Morphogenetic Protein 2 in Respiratory Diseases
    Yiqiong Wen, Yuanyuan Zheng, Shu Hua, Tongfen Li, Xiaoqing Bi, Qiongfen Lu, Min Li, Shibo Sun · 2024 · Current Allergy and Asthma Reports
40. Glutamine transporter inhibitor enhances the sensitivity of NSCLC to trametinib through GSDME-dependent pyroptosis
    Qingxia Liu, Jinxia Hu, Xinzhen Li, Haiwang Gao, Dexin Kong, Meihua Jin · 2025 · Biochemical Pharmacology
41. ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma
    Yanlin Song, Yuan Cheng, Tianxia Lan, Ziyi Bai, Yü Liu, Zhenfei Bi, Aqu Alu, Diou Cheng, Yuquan Wei, Xiawei Wei · 2022 · Cancer Letters
42. Oncology Drug Repurposing for Sepsis Treatment
    Izabela Rumieńczyk, Maria Kulecka, Małgorzata Statkiewicz, Jerzy Ostrowski, Michał Mikuła · 2022 · Biomedicines
43. The carboxymethylated derivative of laminaran from brown alga Saccharina cichorioides: Structure, anticancer and anti-invasive activities in 3D cell culture
    Olesya S. Malyarenko, Roza V. Usoltseva, Anton B. Rasin, Svetlana Pavlovna Ermakova · 2022 · International Journal of Biological Macromolecules
44. Identifying key transcription factors and immune infiltration in non-small-cell lung cancer using weighted correlation network and Cox regression analyses
    Jingyao Zhang, Yinuo Wang, Baowen Yuan, Hao Qin, Yong Wang, Hefen Yu, Xu Teng, Yunkai Yang, Jun Zou, Min Zhang et al. · 2023 · Frontiers in Oncology
45. Tetrandrine for Targeting Therapy Resistance in Cancer
    Ellen Nogueira Lima, Santosh Lamichhane, Pramod Bahadur K. C, Elisa S. Ferreira, Sweaty Koul, Hari K. Koul · 2024 · Current Topics in Medicinal Chemistry
46. Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors
    Shuai Wen, Huan Xiao, Panpan Yang, Yiwen Zhang, Faqian Bu, Yongya Wu, Qiu Sun, Guan Wang, Liang Ouyang · 2024 · Journal of Medicinal Chemistry
47. Extracellular vesicles of Clonorchis sinensis promote the malignant phenotypes of cholangiocarcinoma via NF-κB/EMT axis
    Xiaowen Pan, Qing He, Yingxuan Yin, Anyuan Xu, Aoxun Wu, Xueqing Yi, Zhifeng Zhong, Yinjuan Wu, Xuerong Li · 2024 · PLoS neglected tropical diseases
48. Pyrazolopyrimidines: A Promising Frontier in Cancer Treatment‐Reviewing Their Potential as Inhibitors of Serine/Threonine Kinases
    Ahmed M. Abdelhamed, Amira Atef Helwa, Hanan H. Kadry, Rasha A. Hassan · 2025 · Chemistry & Biodiversity
49. Tumor Small Extracellular Vesicle‐Transmitted LncRNA CATED Promotes Platinum‐Resistance in High‐Grade Serous Ovarian Cancer
    Yi Liu, Hanyuan Liu, Chenchen Zhu, Yan Yang, Zhen Shen, Ge Shan, Liang Chen, Ying Yin Zhou · 2025 · Advanced Science
50. SPP1+ macrophages polarized by lactate confer the progression of hypoxic adaptive tumor cells in brain
    Jianlei Zhang, Zhihui Li, Jiang Yin, Weina Fan, Hongfan Liao, Jing Dong, Xianfeng Yu, Yabing Cao, Qiong Zhang, Guopei Zheng et al. · 2025 · Neuro-Oncology
51. Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances
    Yue Chen, Jiaqi Zhang, Yi Ding, Fang Zhu, Yinnan Chen · 2026 · Molecular Biomedicine
52. Adverse Effects of Vemurafenib on Skin Integrity: Hyperkeratosis and Skin Cancer Initiation Due to Altered MEK/ERK-Signaling and MMP Activity
    Marius Tham, Hans‐Jürgen Stark, Anna Sophia Jauch, Catherine A Harwood, Elizabeth Pavez Loriè, Petra Boukamp · 2022 · Frontiers in Oncology
53. Discovery of YS-363 as a highly potent, selective, and orally efficacious EGFR inhibitor
    Pengxing He, Jing Jing, Linna Du, Xuyang Zhang, Yufei Ren, Han Yang, Bin Yu, Hong‐Min Liu · 2023 · Biomedicine & Pharmacotherapy
54. Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway
    Na Song, Kai Cui, Liqun Zeng, Yanwu Fan, Ziwei Wang, Pingyu Shi, Wei Su, Haijun Wang · 2024 · Journal of Proteomics
55. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants
    Shu-Yi Chen, Jing Gu, Kaichun Wu, Xiaodi Zhao, Yuanyuan Lu · 2024 · Cancer Biology and Medicine
56. A spotlight on the role of copper in the epithelial to mesenchymal transition
    Antonio Focaccio, Luisa Carlotta Rossi, Anastasia De Luca · 2024 · Life Sciences
57. CASZ1: Current Implications in Cardiovascular Diseases and Cancers
    Heng Jian, Ansgar Poetsch · 2023 · Biomedicines
58. Low TYROBP expression predicts poor prognosis in multiple myeloma
    Hong Luo, Chengyun Pan, Li Wang, Lin Zheng, Shuyun Cao, Xiuying Hu, Tianzhen Hu, Naiqin Zhao, Qin Shang, Jishi Wang · 2024 · Cancer Cell International
59. Reverse repurposing: Potential utility of cancer drugs in nonmalignant illnesses
    Mina Nikanjam, Kaitlyn Wells, Shumei Kato, Jacob J. Adashek, Shanna Block, Razelle Kurzrock · 2024 · Med
60. CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer
    Qian Dai, Xufeng Yao, Yanke Zhang, Qian Chai, Xueyi Feng, Hongbin Zhu, Lei Zhao · 2024 · Journal of Cancer Research and Clinical Oncology
61. Allele frequency in thyroid cancer: mechanisms, challenges, and applications in cancer therapy
    Jiayu Huang, Jiazhi Wang, Guangzhi Wang, Yongfu Zhao · 2025 · Thyroid Research
62. Role of ERK1/2 and p38 Protein Kinases in Tumors: Biological Insights and Clinical Implications
    Aleksandra Emelyanova, Alexander Modestov, Anton A. Buzdin, Elena V Poddubskaya · 2025 · Frontiers in Bioscience-Landmark
63. Bivalent activity of super-enhancer RNA LINC02454 controls 3D chromatin structure and regulates glioma sensitivity to temozolomide
    Tengfei Shi, Dianhao Guo, Yaoqiang Zheng, Wenbin Wang, Jinfang Bi, Anshun He, Sibo Fan, Guangsong Su, Xueyuan Zhao, Zhenhao Zhao et al. · 2024 · Cell Death and Disease
64. TATA-box-binding protein-associated factor 15 is a novel biomarker that promotes cell proliferation and migration in gastrointestinal stromal tumor
    Cheng-Ming Guo, Tang Li, Li Xu, Liu‐Ye Huang · 2023 · World Journal of Gastroenterology
65. TREM1 promotes cancer associated malignant phenotype through activated MAPK signaling pathway and predicts poor prognosis in gastric cancer
    Long Chen, Fen Huang, Xiaopan Luo, Zan Chen · 2024 · Heliyon
66. Detection of genetic mutations in 855 cases of papillary thyroid carcinoma by next generation sequencing and its clinicopathological features
    Dongliang Shi, Meihong Yao, Dan Wu, Meichen Jiang, Junkang Li, Yuhui Zheng, Yinghong Yang · 2024 · Diagnostic Pathology
67. Targeting MXD1 sensitises pancreatic cancer to trametinib
    Shaoping Zhang, Shuang Deng, Ji Liu, Shuang Liu, Ziming Chen, Shaoqiu Liu, Chunling Xue, Lingxing Zeng, Hongzhe Zhao, Zilan Xu et al. · 2025 · Gut
68. Depletion of Acetyl‐CoA Carboxylase 1 Facilitates Epithelial‐Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway
    Jiarun Lai, Shaoyou Liu, Yupeng Chen, Jian Chen, Jinchuang Li, Zhenguo Liang, Xinyue Mei, Yuanfa Feng, Zhaodong Han, Funeng Jiang et al. · 2025 · MedComm
69. DUSP4 inhibited tumor cell proliferation by downregulating glycolysis via p-ERK/p-PGK1 signaling in ovarian cancer
    Ying Xiong, Xiaoqian Zhang, Weiwei Xie, Yujia Yin, Yujing Qian, Xiang Ying, Xiaocui Zheng, Xipeng Wang · 2025 · Cancer Cell International
70. Integrative network pharmacology, transcriptomics, and proteomics reveal the material basis and mechanism of the Shen Qing Weichang Formula against gastric cancer
    Yi Wang, Xiaoyu Sun, Mingming Ren, Fangqi Ma, Ruohan Zhao, Xiaohong Zhu, Yan Xu, Nida Cao, Yuanyuan Chen, Yongfu Pan et al. · 2025 · Chinese Medicine
71. Effects of polyunsaturated fatty acids on gastric cancer immunity and immunotherapy
    Wu Dong, Fan Fan, Junxian He, Lian Wang, Caiyun Zhu, Yalin Ji, Haijun Zhang · 2025 · Scientific Reports
72. Progress in the pathogenesis and treatment of pituitary neuroendocrine tumors (PitNETs): From molecular mechanisms to emerging therapies
    Na Wu, Naijia Wu, Nan Wang, Yonghong Zhu · 2025 · Molecular and Cellular Probes
73. Treponema pallidum inhibits CD4+ T-cell proliferation through METAP2: insights from Mendelian randomization analysis
    Zhaoping Liu, Xiaohong Zhang, Ting Yu Lin, Xuan Ding, Yu Han, Jiangchen Yao, Ke Gao, Yimou Wu, Feijun Zhao · 2025 · AMB Express
74. Re‐Innovation in Clinical Trial Designs Based on Precision Therapy
    Shenglan Li, Jiachen Wang, Zhuang Kang, Xun Kang, Feng Chen, Wenbin Li · 2025 · Cancer Innovation
75. Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights
    Wen Xiao, Dan Tan, Wen Zeng, Xiaoming Nie, Mingliang Wang · 2026 · Genes & Diseases
76. Cancer drug repurposing in autism spectrum disorder
    Giorgia Pedini, Chin‐Lin Chen, Tilmann Achsel, Claudia Bagni · 2023 · Trends in Pharmacological Sciences
77. RUVBL1 accelerates tongue squamous cell carcinoma by mediating CRaf/MEK/ERK pathway
    Xinyu Zhang, Yang Liu, Qiong Rong, Ming-yue Qi, Hui Guo · 2024 · iScience
78. Insight into the regulatory mechanism of β‐arrestin2 and its emerging role in diseases
    Qi Meng, Tingting Chen, Ling Li, Ping‐Ping Gao, Nan Li, Shi-hao Zhang, Wei Wei, Wu‐Yi Sun · 2024 · British Journal of Pharmacology
79. Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer
    Rajibul Islam, Khor Poh Yen, Nur Najihah Izzati Mat Rani, Md. Selim Hossain · 2024 · Bioorganic & Medicinal Chemistry
80. RPL36A activates ERK pathway and promotes colorectal cancer growth
    Shi Jing, Yebin Yang, Fangci Chen, Linpo Zhou, Haoran Wei, Fanhe Dong, Xiang Wang, Yuqiang Shan, Tianwei Chen · 2024 · Translational Oncology
81. JianPiTongLuo (JPTL) Recipe regulates anti-apoptosis and cell proliferation in colorectal cancer through the PI3K/AKT signaling pathway
    Jinyan Chu, Chenyue Yuan, Lin Zhou, Yong Zhao, Xingli Wu, Yuting Yan, Yi Liu, Xiangjun Liu, Lin Jing, Tiangeng Dong et al. · 2024 · Heliyon
82. Distinct clinical profiles and patient outcomes in aCML and CNL
    Yingxin Sun, Qinrong Wang, Zhiyu Zhang, Qian Wang, Jiannong Cen, Mingqing Zhu, Jinlan Pan, Dandan Liu, Hongjie Shen, Yifeng Cai et al. · 2024 · Annals of Hematology
83. Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis
    Matthew D. Gregory, Kweku Ofosu-Asante, Jassy Mary S. Lazarte, Pablo E. Puente, Nada Tawfeeq, Nadine L. Belony, Yong Hong Huang, Ite A. Laird‐Offringa, Nazarius Saah Lamango · 2024 · PLoS ONE
84. Fc gamma receptors activate different protein kinase C isoforms in human neutrophils
    Omar Rafael Alemán, Carlos Blanco-Camarillo, Nathalia Naranjo-Pinto, Nancy Mora, Carlos Rosales · 2025 · Journal of Leukocyte Biology
85. Extracellular vesicle-mediated gene therapy targets BRAFV600E-mutant colorectal cancer by inhibiting the MEK1/2-ERK1/2 pathway
    Di Wang, Liwei Wang, Wei Zhang, Kaicheng Xu, Liang Chen, Ziye Guo, Kaile Wu, Donghua Huang, Yubin Zhao, Minjun Yao et al. · 2025 · Journal of Nanobiotechnology
86. Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon
    Dequan Liu, Lei Liu, Xiaoman Zhang, Xinming Zhao, Xiaorui Li, Xiangyu Che, Guangzhen Wu · 2025 · Molecular Aspects of Medicine
87. Enhancing KRAS G12D inhibitor sensitivity in pancreatic cancer through SHP2/PI3K pathway
    Man-Wei Hao, Tian‐Xing Zhang, Dan Feng Dong, Xin Min ZHOU, Haicheng Gao · 2025 · Medical Oncology
88. Shared mechanisms for metastasis and drug resistance in prostate cancer
    Yimin Chen, Lin Chen, Yuxin Xu, Haibo Cheng, Jian‐Liang Zhou · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
89. EDIL3 regulates pulmonary artery smooth muscle cell proliferation and migration via integrin αVβ3/ERK1/2 axis in pulmonary hypertension
    Chao Gao, Jiaqi Li, Fan Feng, Jia Fu, Ting Gong, Shukun Cao, Qian Li, Yongbing Wang, Na Sun, Bingxiang Wu et al. · 2025 · European Journal of Pharmacology
90. Signaling to make human ribosomes: Connections between the cytoplasm and the nucleolus
    Isabella Rachel Lawrence, Emily C. Sutton, Shivang Bhaskar, Susan J. Baserga · 2026 · Molecular Cell
91. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2‐AS2/MEK/ERK/STAT3 signaling
    Lele Ling, Yichao Wen, Ying Xiong, Xin Liu, Juan Chen, Te Liu, Bimeng Zhang · 2023 · The Journal of Gene Medicine
92. Engagement of AKT and ERK signaling pathways facilitates infection of human neuronal cells with West Nile virus
    Wan-Da Tang, Wei-Yang Zhu, Hailin Tang, Ping Zhao, Lan‐Juan Zhao · 2024 · Journal of Virus Eradication
93. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells
    Yongjia Gao, Junyi Hou, Xiaobin Fei, Likun Ren, R. Lu, Peng Liu, Songbai Liu, Changhao Zhu, Xing Wang, Yaozhen Pan · 2024 · Cellular Signalling
94. Pin1 as a central node in oncogenic signaling: Mechanistic insights and clinical prospects (Review)
    Shuning Lei, Min Luo, Yuxue Wang · 2025 · Molecular Medicine Reports
95. Thienopyrimidine: A promising scaffold in the development of kinase inhibitors with anticancer activities
    Yunhe Liu, Ziyue Wang, Yifei Du, Xuan-Han Liu, Jin-Bo Niu, Jian H. Song, Cheng‐Yun Jin, Sai‐Yang Zhang · 2025 · Bioorganic & Medicinal Chemistry
96. TOMM34 promotes cell proliferation, migration, and invasion of OSCC and modulates mitochondrial function
    Yunyi Huang, Zhipei Chen, Xuanyi Chen, Xiaohua Chen, Meng Qing Xu · 2022 · Journal of Oral Pathology and Medicine
97. Oncogenic ERRB2 signals through the AP-1 transcription factor to control mesenchymal-like properties of oesophageal adenocarcinoma
    Samuel Ogden, Ibrahim Ahmed, Shen‐Hsi Yang, Paul Fullwood, Chiara Francavilla, Andrew D Sharrocks · 2023 · NAR Cancer
98. OxLDL-Stimulated Macrophages Transmit Exosomal MicroRNA-320b to Aggravate Viability, Invasion, and Phenotype Switching via Regulating PPARGC1A-Mediated MEK/ERK Pathway in Proatherogenic Vascular Smooth Muscle Cells
    Lingyun Ren, Shanshan Chen, Wei Liu · 2023 · The Tohoku Journal of Experimental Medicine
99. The Prognostic Biomarker RAB7A Promotes Growth and Metastasis of Liver Cancer Cells by Regulating Glycolysis and YAP1 Activation
    Jun‐Yuan Zhang, Xilin Zhu, Ying Liu, Xiaopan Wu · 2024 · Journal of Cellular Biochemistry
100. Reprogramming tumor-associated macrophages: The role of MEK-STAT3 inhibition in lung cancer
     Sushama Rawat, Ehssan H. O. Moglad, Muhammad Afzal, Ahsas Goyal, R Roopashree, Pooja Bansal, Shivang Mishra, G.V. Siva Prasad, Atreyi Pramanik, Sami Ibrahim Alzarea et al. · 2024 · Pathology - Research and Practice